Qube Research & Technologies LTD Igm Biosciences, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$6.66 - $10.64 $6,233 - $9,959	936 New	936 $7,000
Q1 2022 May 09, 2022	SELL	$13.42 - $29.73 $432,150 - $957,365	-32,202 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$27.59 - $66.39 $888,453 - $2.14 Million	32,202 New	32,202 $944,000
Q4 2020 Feb 16, 2021	SELL	$47.41 - $115.03 $158,918 - $385,580	-3,352 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$43.0 - $84.01 $144,136 - $281,601	3,352 New	3,352 $247,000
Q2 2020 Aug 14, 2020	SELL	$51.3 - $75.21 $447,438 - $655,981	-8,722 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$31.51 - $73.75 $274,830 - $643,247	8,722 New	8,722 $490,000

21.4M

39.5K

16.5K

Ticker IGMS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,969,000
Market Cap $500M
Description
IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.